Guanfacine intoxication in a young child presenting with prolonged somnolence and sinus bradycardia: a case report
Guanfacine, a medication used to treat attention deficit hyperactivity disorder (ADHD), activates alpha-2A adrenergic receptors in the brain to reduce symptoms. However, its central alpha-2 agonist activity can cause adverse events, such as somnolence, bradycardia, and hypotension. We present the case of a 6-year-old boy (15 kg) with no history of regular medication use who was admitted to the hospital with unexplained prolonged somnolence and bradycardia. Initial evaluation ruled out common causes; however, ingestion of his mother's prescription medication was suspected. Liquid chromatography-quadrupole time-of-flight mass spectrometry confirmed the presence of 6 ng/mL of guanfacine in his serum, which, together with his symptoms, led to a diagnosis of guanfacine intoxication. To our knowledge, this is the first report of guanfacine intoxication in a young child without ADHD with documented serum concentration measurements. This case may help in the recognition and diagnosis of guanfacine toxicity in pediatric patients.
Authors
- Hiroshi Okada (ORCID: https://orcid.org/0000-0002-0809-8167)
- Sayaka Nagasawa (ORCID: https://orcid.org/0000-0002-0977-5043)
- Go Inokuchi (ORCID: https://orcid.org/0000-0002-3654-5702)
- Hirotaro Iwase (ORCID: https://orcid.org/0000-0001-9309-8841)
- Minami Daikai
Institutions
- Chiba University (JP)
- Matsudo City Hospital (JP)
Publication Details
- Journal
- Journal of Analytical Toxicology
- Published
- 2025-08-20
- DOI
- https://doi.org/10.1093/jat/bkaf080
- Primary Topic
- Attention Deficit Hyperactivity Disorder
- Type
- article
- Field-Weighted Citation Impact
- 0.00